×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש
××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ×
×רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
× ×ª×× × ×ª×¨×פ×
××רש×
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L01EX
Other protein kinase inhibitors
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
פ××× - PER OS
|
| צ×רת ××× ××
|
×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
Sorafenib Teva is indicated for the treatment of:⢠patients with advanced renal cell carcinoma. ⢠patients with hepatocellular carcinoma⢠patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 01/03/2008
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| סר×× ×××× ×תק×× ×× ×ר××¨×ª× (×× ××§× ××פ×× ×¨×ש××). |
30/01/2020 |
××× ×§×××××× |
|
Renal cell carcinoma |
|
| סר×× ×××× ×תק×× ×× ×ר××¨×ª× (×× ××§× ××פ×× ×¨×ש××). ××××× ××××ª× ×××× ××××× ×××× ×××פ×× ×ש××ש תר×פ×ת ×××× ××תר×פ×ת ××פ×ר××ת ×××× - Sunitinib, Sorafenib, Everolimus, Temsirolimus, Pazopanib, Axitinib, Nivolumab. ×××פ×× ×ת×ש×ר ×× ××× ×ª× ×ש×××× ×¢× Nivolumab ×× ×¢× ×ª×¨××¤× ××שפ×ת ××¢××× mTOR. |
12/01/2017 |
××× ×§×××××× |
|
Renal cell carcinoma |
|
סר×× ×תק×× ×ק××× ×× ×ר××¨×ª× ×©× ××××ת ×תר×ס ×ס×× DTC (Differentiated (papillary / follicular / Hurthle cell) thyroid carcinoma) ×¢××× ×××× ×¨××××ק×××× |15/01/2015||××× ×§××××××|| ||Differentiated thyroid carcinoma, DTIC||
| סר×× ×××× ×תק×× ×× ×ר××¨×ª× (×× ××§× ××פ×× ×¨×ש××). ××××× ××××ª× ×××× ××××× ×××× ×××פ×× ××©×ª× ×ª×¨×פ×ת ×××× ××תר×פ×ת ××פ×ר××ת ×××× â SUNITINIB, SORAFENIB, EVEROLIMUS, TEMSIROLIMUS. |
03/01/2010 |
××× ×§×××××× |
|
Renal cell carcinoma |
|
| סר×× ×פ××צ××××¨× ×תק×× ×××××× ×××××ר×× ×-Child Pugh's A. |
â01/01/2009 |
|
××× ×§×××××× |
|
Hepatocellular carcinoma |
|
| ×תר××¤× ×ª×× ×ª× ×××פ×× ×סר×× ×××× ×תק××. ק××× ××××× ××פ×× ×××ת ××תר×פ×ת Sorafenib ×× Sunitinb, ×× ×ק×× ××פ×× ×תר××¤× ×××רת |
01/03/2008 |
××× ×§×××××× |
|
Renal cell carcinoma |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- 1. ×תר××¤× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- ×. סר×× ×××× ×תק×× ×× ×ר××¨×ª× (×× ××§× ××פ×× ×¨×ש××).
- ×. סר×× ×פ××צ××××¨× ×תק×× ×××××× ×××××ר×× ×-Child Pugh's A
- ×. סר×× ×תק×× ×ק××× ×× ×ר××¨×ª× ×©× ××××ת ×תר×ס ×ס×× DTC (Differentiated (papillary / follicular / Hurthle cell) thyroid carcinoma) ×¢××× ×××× ×¨××××ק××××.
- ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ×××× ×§×××××× ×× ××××× ×××ר×××××× ××××¤× ×××ר×××××× ××× ×§×××××ת.
|
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
××× ×¢××× ×ר×פ×
Â
|
| ××פ×ש ×××ר××
|
×××ר×× ×-PubMed
|
| ××××¢ ×רשת
|
RxList WebMD Drugs.com
|
| ×©× ×צר×
|
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
|
| ×©× ××¢× ×ר×ש××
|
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
|
| ר×ש×××
|
ת×ר×× ××ש×: 12/2017. ר×ש××× ×ת×ר××:
|
| ת×ר×× ×¢×××× ××ר××
|
06/06/2024
|
ת×ר×× ×¢××××: 06/06/2024
TEVA
ס××¨×¤× ×× - Sorafenib
true
השינוי האחרון נעשה בֹ־15 בספטמבר 2025 ב־10:35
